Medication description: Exosurf for newborns (Exosurf neonatal)
EXOSURF FOR NEWBORN (Exosurf neonatal).
The active ingredient of exosurf is colfosceril palmitate (Colfosceril palmitate).
It has the properties of surfactant and improves the stretchability of the lungs.
It is applied, like kurosurf, with respiratory distress syndrome in newborns.
Enter in the form of a solution in a dose of 5 ml / kg through the endotracheal tube. If necessary, repeat the introduction in the same dose after 12 hours.
Product form: powder in ampoules of 0.108 g of colfocerol palmitate with the addition of other components complete with a solvent (water for injection) in 8 ml ampoules.